SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-18-000292
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:34
Documents
79
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 2024984
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 10135
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 10388
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 6737
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 6584
  Complete submission text file 0001513162-18-000292.txt   8293319

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vxrt-20180930.xml EX-101.INS 2004699
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vxrt-20180930.xsd EX-101.SCH 70756
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vxrt-20180930_cal.xml EX-101.CAL 56914
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vxrt-20180930_def.xml EX-101.DEF 338747
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vxrt-20180930_lab.xml EX-101.LAB 460951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vxrt-20180930_pre.xml EX-101.PRE 336388
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 181177956
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1